Clinical6 Software and Technical Services

The National Institutes of Health intends to negotiate on a sole source basis with Parallel6, Inc.

The National Institutes of Health (NIH), National Eye Institute (NEI) eyeGENE® was initiated in 2004, the program scope was narrowly defined as relating to only vision research. Since that time, both Institutional and Review Board leadership has requested an expanded scope of the consent agreement to include end-points that may not be strictly vision related or that may have unknown biological consequences. This change in requirement requires that the program staff contact over 6,000 participants to get consent for the types of research that is desired. Additionally, the program has new requirements related to patient engagement as it seeks to obtain additional clinical information from participants. The program seeks to implement and acquire a software license for Clinical6 software solution to address the new program requirements.
¬
Please see the attached J&A, for further information.

Responses
The proposed acquisition action is for items and services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1. If you believe you can provide the services requested, all responsible sources may submit a capability statement, which shall be considered by the agency anne.mineweaser@nih.gov referencing notice number NIH-OLAO-OD3-NOI4575084 by 12PM, July, 24, 2017. A determination by the Government not to compete this proposed contract acquisition based upon responses to the notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

Any solicitation resulting from the analysis of information obtained will be announced to the public in Federal Business Opportunities in accordance with the FAR Part 5. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).